These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20219367)

  • 21. Design, synthesis, and structure-activity relationships of spirolactones bearing 2-ureidobenzothiophene as acetyl-CoA carboxylases inhibitors.
    Yamashita T; Kamata M; Endo S; Yamamoto M; Kakegawa K; Watanabe H; Miwa K; Yamano T; Funata M; Sakamoto J; Tani A; Mol CD; Zou H; Dougan DR; Sang B; Snell G; Fukatsu K
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6314-8. PubMed ID: 21944854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain acetyl-CoA carboxylase: isozymic identification and studies of its regulation during development and altered nutrition.
    Spencer EB; Bianchi A; Widmer J; Witters LA
    Biochem Biophys Res Commun; 1993 Apr; 192(2):820-5. PubMed ID: 8097913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and structure-activity relationships of N-{3-[2-(4-alkoxyphenoxy)thiazol-5-yl]-1- methylprop-2-ynyl}carboxy derivatives as selective acetyl-CoA carboxylase 2 inhibitors.
    Gu YG; Weitzberg M; Clark RF; Xu X; Li Q; Zhang T; Hansen TM; Liu G; Xin Z; Wang X; Wang R; McNally T; Zinker BA; Frevert EU; Camp HS; Beutel BA; Sham HL
    J Med Chem; 2006 Jun; 49(13):3770-3. PubMed ID: 16789734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent biphenyl- and 3-phenyl pyridine-based inhibitors of acetyl-CoA carboxylase.
    Haque TS; Liang N; Golla R; Seethala R; Ma Z; Ewing WR; Cooper CB; Pelleymounter MA; Poss MA; Cheng D
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5872-6. PubMed ID: 19740659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mass spectrometry in high-throughput screening: a case study on acetyl-coenzyme a carboxylase using RapidFire--mass spectrometry (RF-MS).
    Jonas M; LaMarr WA; Ozbal C
    Comb Chem High Throughput Screen; 2009 Sep; 12(8):752-9. PubMed ID: 19531010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virtual Screening Strategy Combined Bayesian Classification Model, Molecular Docking for Acetyl-CoA Carboxylases Inhibitors.
    Zhou WN; Zhang YM; Qiao X; Pan J; Yin LF; Zhu L; Zhao JN; Lu S; Lu T; Chen YD; Liu HC
    Curr Comput Aided Drug Des; 2019; 15(3):193-205. PubMed ID: 30411690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetyl-CoA carboxylase inhibition for the treatment of metabolic syndrome.
    Harwood HJ
    Curr Opin Investig Drugs; 2004 Mar; 5(3):283-9. PubMed ID: 15083594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acetyl-CoA carboxylase (ACC) as a therapeutic target for metabolic syndrome and recent developments in ACC1/2 inhibitors.
    Chen L; Duan Y; Wei H; Ning H; Bi C; Zhao Y; Qin Y; Li Y
    Expert Opin Investig Drugs; 2019 Oct; 28(10):917-930. PubMed ID: 31430206
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthesis and biological evaluation of 4-phenoxy-phenyl isoxazoles as novel acetyl-CoA carboxylase inhibitors.
    Wu X; Yu Y; Huang T
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1236-1247. PubMed ID: 34100310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient search of chemical space: navigating from fragments to structurally diverse chemotypes.
    Wassermann AM; Kutchukian PS; Lounkine E; Luethi T; Hamon J; Bocker MT; Malik HA; Cowan-Jacob SW; Glick M
    J Med Chem; 2013 Nov; 56(21):8879-91. PubMed ID: 24117015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review of recent acetyl-CoA carboxylase inhibitor patents: mid-2007-2008.
    Corbett JW
    Expert Opin Ther Pat; 2009 Jul; 19(7):943-56. PubMed ID: 19552511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of acetyl-CoA carboxylase isoforms by pyridoxal phosphate.
    Lee WM; Elliott JE; Brownsey RW
    J Biol Chem; 2005 Dec; 280(51):41835-43. PubMed ID: 16249179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting acetyl-CoA carboxylases: small molecular inhibitors and their therapeutic potential.
    Luo DX; Tong DJ; Rajput S; Wang C; Liao DF; Cao D; Maser E
    Recent Pat Anticancer Drug Discov; 2012 May; 7(2):168-84. PubMed ID: 22339356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, Biological Evaluation and Molecular Docking Studies of Piperidinylpiperidines and Spirochromanones Possessing Quinoline Moieties as Acetyl-CoA Carboxylase Inhibitors.
    Huang T; Sun J; Wang Q; Gao J; Liu Y
    Molecules; 2015 Sep; 20(9):16221-34. PubMed ID: 26370948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treating the metabolic syndrome: acetyl-CoA carboxylase inhibition.
    Harwood HJ
    Expert Opin Ther Targets; 2005 Apr; 9(2):267-81. PubMed ID: 15934915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A different mechanism for the inhibition of the carboxyltransferase domain of acetyl-coenzyme A carboxylase by tepraloxydim.
    Xiang S; Callaghan MM; Watson KG; Tong L
    Proc Natl Acad Sci U S A; 2009 Dec; 106(49):20723-7. PubMed ID: 19926852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of Novel Selective Acetyl-CoA Carboxylase (ACC) 1 Inhibitors.
    Mizojiri R; Asano M; Tomita D; Banno H; Nii N; Sasaki M; Sumi H; Satoh Y; Yamamoto Y; Moriya T; Satomi Y; Maezaki H
    J Med Chem; 2018 Feb; 61(3):1098-1117. PubMed ID: 29232514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression analysis in rats treated with experimental acetyl-coenzyme A carboxylase inhibitors suggests interactions with the peroxisome proliferator-activated receptor alpha pathway.
    Waring JF; Yang Y; Healan-Greenberg CH; Adler AL; Dickinson R; McNally T; Wang X; Weitzberg M; Xu X; Lisowski A; Warder SE; Gu YG; Zinker BA; Blomme EA; Camp HS
    J Pharmacol Exp Ther; 2008 Feb; 324(2):507-16. PubMed ID: 18025247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of phosphorylation by AMP-activated protein kinase on palmitoyl-CoA inhibition of skeletal muscle acetyl-CoA carboxylase.
    Rubink DS; Winder WW
    J Appl Physiol (1985); 2005 Apr; 98(4):1221-7. PubMed ID: 15579580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of acetyl-coenzyme A carboxylase 2 inhibitors: comparison of a fluorescence intensity-based phosphate assay and a fluorescence polarization-based ADP Assay for high-throughput screening.
    Liu Y; Zalameda L; Kim KW; Wang M; McCarter JD
    Assay Drug Dev Technol; 2007 Apr; 5(2):225-35. PubMed ID: 17477831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.